


Anadys Pharmaceuticals Revenue
Medical Practices • United States • 1-10 Employees
Anadys Pharmaceuticals revenue & valuation
| Annual revenue | $855,550 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Practices industry and current estimated revenues | $2,800,000 |
| Total funding | $17,500,000 |
Key Contact at Anadys Pharmaceuticals
Vince Reardon
Sr. Director, Investor Relations & Corp Communications
Company overview
| Headquarters | United States |
| Websites | |
| NAICS | 62 |
| SIC | 283 |
| Keywords | Modafinil And Armodafinil |
| Employees | 1-10 |
| Socials |
About Anadys Pharmaceuticals
Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Anadys Pharmaceuticals has 5 employees across 5 departments.
Departments
Number of employees
Anadys Pharmaceuticals Tech Stack
Discover the technologies and tools that power Anadys Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Security
WordPress themes
Databases
Caching
Performance
JavaScript libraries
CDN
JavaScript libraries
WordPress plugins
Miscellaneous
Security
Programming languages
Frequently asked questions
4.8
40,000 users



